RhumbLine Advisers’s Surgery Partners SGRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.56M | Sell |
|
|||||
|
2025
Q2 | $2.7M | Buy |
|
|||||
|
2025
Q1 | $2.79M | Sell |
|
|||||
|
2024
Q4 | $2.58M | Buy |
|
|||||
|
2024
Q3 | $3.88M | Sell |
|
|||||
|
2024
Q2 | $3.04M | Buy |
|
|||||
|
2024
Q1 | $3.19M | Buy |
|
|||||
|
2023
Q4 | $3.14M | Buy |
|
|||||
|
2023
Q3 | $2.81M | Buy |
|
|||||
|
2023
Q2 | $4.06M | Buy |
|
|||||
|
2023
Q1 | $2.46M | Buy |
|
|||||
|
2022
Q4 | $1.82M | Buy |
|
|||||
|
2022
Q3 | $1.21M | Buy |
|
|||||
|
2022
Q2 | $1.38M | Buy |
|
|||||
|
2022
Q1 | $1.98M | Buy |
|
|||||
|
2021
Q4 | $1.84M | Buy |
|
|||||
|
2021
Q3 | $1.4M | Buy |
|
|||||
|
2021
Q2 | $2.1M | Buy |
|
|||||
|
2021
Q1 | $1.27M | Sell |
|
|||||
|
2020
Q4 | $849K | Buy |
|
|||||
|
2020
Q3 | $608K | Sell |
|
|||||
|
2020
Q2 | $365K | Sell |
|
|||||
|
2020
Q1 | $254K | Buy |
|
|||||
|
2019
Q4 | $545K | Buy |
|
|||||
|
2019
Q3 | $254K | Buy |
|
|||||
|
2019
Q2 | $258K | Buy |
|
|||||
|
2019
Q1 | $297K | Sell |
|
|||||
|
2018
Q4 | $261K | Buy |
|
|||||
|
2018
Q3 | $310K | Sell |
|
|||||
|
2018
Q2 | $282K | Buy |
|
|||||
|
2018
Q1 | $291K | Sell |
|
|||||
|
2017
Q4 | $212K | Hold |
|
|||||
|
2017
Q3 | $181K | Buy |
|
|||||
|
2017
Q2 | $377K | Hold |
|
|||||
|
2017
Q1 | $323K | Buy |
|
|||||
|
2016
Q4 | $250K | Sell |
|
|||||
|
2016
Q3 | $402K | Buy |
|
|||||
|
2016
Q2 | $352K | Buy |
|
|||||
|
2016
Q1 | $189K | Buy |
|